Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10745 - 10752 of 12008 results
Final Regulations Issued under the Mental Health Parity and Addiction Equity Act of 2008
December 13, 2013| Advisory| Viewpoint
Spiked Egg Nog and the Human Response: Avoiding Holiday Party Mishaps
December 12, 2013| Blog| Viewpoint
25 YEARS AFTER THE SHARK: SUPREME COURT RULING ON THE NCAA CASTS A SHADOW ON CURRENT INVESTIGATIONS
December 12, 2013| Blog| Viewpoint
On the Fourth Day of Privacy, the Internet gave to me....
December 12, 2013| Blog| Viewpoint
‘Tis The Season for Massachusetts’ Temporary Employees
December 11, 2013| Blog| Viewpoint
On the Third Day of Privacy, My Smartphone Followed Me…
December 11, 2013| Blog| Viewpoint
DoD Requires Safeguarding Technical Data
December 11, 2013| Blog| Viewpoint
Data Security Advisory for Federal Contractors: Safeguarding Unclassified Controlled Technical Information
December 11, 2013| Advisory| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|